You have 9 free searches left this month | for more free features.

donor chimerism,

Showing 26 - 50 of 3,438

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Immune Tolerance Trial in Palo Alto (Combined Deceased Donor Kidney and Hematopoietic Cell Transplants)

Enrolling by invitation
  • Immune Tolerance
  • Combined Deceased Donor Kidney and Hematopoietic Cell Transplants
  • Palo Alto, California
    Stanford University
May 6, 2022

Blood Disease Trial (TCRaß+/CD19+ depleted Hematopoietic stem cell (HSC) graft, CliniMACS® System)

Not yet recruiting
  • Blood Disease
  • TCRαβ+/CD19+ depleted Hematopoietic stem cell (HSC) graft
  • CliniMACS® System
  • (no location specified)
Jan 30, 2023

Idiopathic Aplastic Anemia, Severe Aplastic Anemia, Moderate Aplastic Anemia Requiring Transfusions Trial (HSCT Arm group)

Not yet recruiting
  • Idiopathic Aplastic Anemia
  • +2 more
  • HSCT Arm group
  • (no location specified)
Jun 10, 2022

Sickle Cell Anemia, Beta-thalassemia Major, Diamond-blackfan Anemia Trial in Pittsburgh (CD3/CD19 depleted leukocytes, CD45RA

Recruiting
  • Sickle Cell Anemia
  • +2 more
  • CD3/CD19 depleted leukocytes
  • +6 more
  • Pittsburgh, Pennsylvania
    Children's Hospital of Pittsburgh of UPMC
May 4, 2022

Severe Combined Immune Deficiency (SCID) Trial run by the National Institute of Allergy and Infectious Diseases (NIAID)

Enrolling by invitation
  • Severe Combined Immune Deficiency (SCID)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 24, 2022

Living Donor Kidney Transplantation Trial in Palo Alto, Chicago (Infusion of Donor Hematopoetic Stem Cells and Recipient Tregs)

Recruiting
  • Living Donor Kidney Transplantation
  • Infusion of Donor Hematopoetic Stem Cells and Recipient Tregs
  • Palo Alto, California
  • +1 more
May 6, 2022

MDS, Secondary Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in Aachen, Düsseldorf, Jena (Venetoclax, Amsacrine,

Not yet recruiting
  • Myelodysplastic Syndromes
  • +2 more
  • Aachen, NRW, Germany
  • +2 more
Mar 29, 2023

Multiple Sclerosis Trial (hematopoetic stem cell infusion)

Active, not recruiting
  • Multiple Sclerosis
  • hematopoetic stem cell infusion
  • (no location specified)
Jul 15, 2022

Haplo-identical Transplants in Fanconi Disease

Not yet recruiting
  • Fanconi Syndrome
  • Blood sampling
  • (no location specified)
Jun 6, 2023

Sickle Cell Disease Trial in Amsterdam (Engerix-B)

Recruiting
  • Sickle Cell Disease
  • Amsterdam, Netherlands
    Amsterdam Medical Centre
Jan 6, 2022

Graft Vs Host Disease Trial in New York (Cyclophosphamide, Abatacept, Tacrolimus)

Recruiting
  • Graft Vs Host Disease
  • New York, New York
    NYU Langone Health
Nov 10, 2022

AML, MDS, ALL, Adult Trial in Hackensack, New York (SOC + TSC-100, SOC + TSC-101, Control)

Recruiting
  • AML
  • +2 more
  • SOC + TSC-100
  • +2 more
  • Hackensack, New Jersey
  • +1 more
Aug 11, 2022

Anemia, Sickle Cell Trial in New York (Siplizumab, Exchange Transfusion, Total Body Irradiation)

Recruiting
  • Anemia, Sickle Cell
  • New York, New York
    Columbia University Irving Medical Center
Oct 9, 2023

Kidney Transplant Rejection Trial (MDR-102, Immunosuppressive Agents)

Not yet recruiting
  • Kidney Transplant Rejection
  • MDR-102
  • Immunosuppressive Agents
  • (no location specified)
Apr 4, 2022

Sickle Cell Disease Trial in Memphis (hydroxyurea, azathioprine, alemtuzumab, thioptepa, low dose total body irradiation and

Recruiting
  • Sickle Cell Disease
  • hydroxyurea, azathioprine, alemtuzumab, thioptepa, low dose total body irradiation and sirolimus
  • hydroxyurea, azathioprine, alemtuzumab, thiotepa, plerixafor, low dose total body irradiation, cyclophosphamide and sirolimus
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
May 5, 2022

Intestinal Transplantation Trial in New York (Cell Therapy)

Recruiting
  • Intestinal Transplantation
  • Cell Therapy
  • New York, New York
    Columbia University Irving Medical Center/NYP
Dec 28, 2021

Primary Immune Deficiency Disorder, Immune Deficiency Disease, Bone Marrow Failure Trial in Baltimore (Alemtuzumab, Fludarabine,

Recruiting
  • Primary Immune Deficiency Disorder
  • +2 more
  • Baltimore, Maryland
    Johns Hopkins University
Oct 20, 2022

Bone Marrow Failure Syndromes Trial in Philadelphia (MRD-BMT with Fludarabine-based RIC for Acquired AA, MRD-BMT with

Recruiting
  • Bone Marrow Failure Syndromes
  • MRD-BMT with Fludarabine-based RIC for Acquired AA
  • +2 more
  • Philadelphia, Pennsylvania
    Children's Hospital of Philadelphia
May 6, 2022

SIOD With CKD Stage 3 Through 5, Cystinosis With CKD Stage 3 Through 5, FSGS With CKD Stage 3 Through 5 Trial in Palo Alto

Not yet recruiting
  • SIOD With CKD Stage 3 Through 5
  • +3 more
  • Cyclophosphamide 1200 mg/Kg
  • +8 more
  • Palo Alto, California
    Lucile Packard Children's Hospital
Aug 17, 2022

GVHD Trial in Nantes (drug, radiation, other)

Terminated
  • Graft Versus Host Disease
  • Nantes, France
    Nantes Uh
Jul 13, 2022

Lymphoproliferative Disorders, Autoimmune Lymphoproliferative, Primary T-cell Immunodeficiency Disorders Trial in Bethesda,

Recruiting
  • Lymphoproliferative Disorders
  • +4 more
  • Immunosuppression Only Conditioning
  • +3 more
  • Bethesda, Maryland
  • +1 more
Jan 25, 2023

Acute Myeloid Leukaemia (AML), MDS (MDS) Trial in Germany, Netherlands (Panobinostat)

Active, not recruiting
  • Acute Myeloid Leukaemia (AML)
  • Myelodysplastic Syndromes (MDS)
  • Stuttgart, Baden-Württemberg, Germany
  • +18 more
Dec 13, 2021

Graft-versus-host Disease Trial in New York (Cyclophosphamide, Abatacept, and Tacrolimus for GvHD Prevention)

Active, not recruiting
  • Graft-versus-host Disease
  • Cyclophosphamide, Abatacept, and Tacrolimus for GvHD Prevention
  • New York, New York
    NYU Langone Health
Aug 5, 2022

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Leukemia Trial in United States (drug, procedure, other, radiation)

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • +10 more
  • Jacksonville, Florida
  • +5 more
Aug 14, 2023

Sickle Cell Disease Trial in United States (CD34 selected T-cell depleted allogeneic SCT)

Active, not recruiting
  • Sickle Cell Disease
  • CD34 selected T-cell depleted allogeneic SCT
  • Los Angeles, California
  • +5 more
Sep 27, 2022